Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-06651600 in Alopecia Areata – Long-term Safety and Efficacy (China Extension)
CTR20192303Phase 3Completed
- Sponsor
- Pfizer
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ritlecitinib tosilate in alopecia areata, sponsored by Pfizer. Started Aug 2020; status: completed.
02
Drugs
ritlecitinib tosilate
03
Conditions
alopecia areata
Beyond the preview
Go deeper on CTR20192303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192303.